Gene Review:
NA - neuraminidase
Influenza B virus
- Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Shaw, M.W., Lamb, R.A., Erickson, B.W., Briedis, D.J., Choppin, P.W. Proc. Natl. Acad. Sci. U.S.A. (1982)
- Role of neuraminidase in the morphogenesis of influenza B virus. Yamamoto-Goshima, F., Maeno, K., Morishita, T., Ueda, M., Fujita, Y., Nakajima, K., Yoshii, S. J. Virol. (1994)
- Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture. Colacino, J.M., Laver, W.G., Air, G.M. J. Infect. Dis. (1997)
- Influenza type B neuraminidase can replace the function of type A neuraminidase. Ghate, A.A., Air, G.M. Virology (1999)
- Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. Hayden, F.G., Gubareva, L.V., Monto, A.S., Klein, T.C., Elliot, M.J., Hammond, J.M., Sharp, S.J., Ossi, M.J. N. Engl. J. Med. (2000)
- Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. Hayden, F.G., Atmar, R.L., Schilling, M., Johnson, C., Poretz, D., Paar, D., Huson, L., Ward, P., Mills, R.G. N. Engl. J. Med. (1999)
- Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden, F.G., Osterhaus, A.D., Treanor, J.J., Fleming, D.M., Aoki, F.Y., Nicholson, K.G., Bohnen, A.M., Hirst, H.M., Keene, O., Wightman, K. N. Engl. J. Med. (1997)
- The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. Burmeister, W.P., Ruigrok, R.W., Cusack, S. EMBO J. (1992)
- A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Shaw, M.W., Choppin, P.W., Lamb, R.A. Proc. Natl. Acad. Sci. U.S.A. (1983)
- Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Gubareva, L.V., Webster, R.G., Hayden, F.G. Antimicrob. Agents Chemother. (2001)
- Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. Ison, M.G., Gubareva, L.V., Atmar, R.L., Treanor, J., Hayden, F.G. J. Infect. Dis. (2006)
- Sequence and crystallization of influenza virus B/Beijing/1/87 neuraminidase. Burmeister, W.P., Daniels, R.S., Dayan, S., Gagnon, J., Cusack, S., Ruigrok, R.W. Virology (1991)
- Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. Sudbeck, E.A., Jedrzejas, M.J., Singh, S., Brouillette, W.J., Air, G.M., Laver, W.G., Babu, Y.S., Bantia, S., Chand, P., Chu, N., Montgomery, J.A., Walsh, D.A., Luo, M. J. Mol. Biol. (1997)
- Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. Bilsel, P., Castrucci, M.R., Kawaoka, Y. J. Virol. (1993)
- Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus. Hackett, C.J., Horowitz, D., Wysocka, M., Eisenlohr, L.C. J. Virol. (1991)
- Analysis of the desialidation process of the haemagglutinin protein of influenza B virus: the host-dependent desialidation step. Luo, C., Nobusawa, E., Nakajima, K. J. Gen. Virol. (2002)
- Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. Lambré, C.R., Terzidis, H., Greffard, A., Webster, R.G. J. Immunol. Methods (1990)
- A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies. White, C.L., Janakiraman, M.N., Laver, W.G., Philippon, C., Vasella, A., Air, G.M., Luo, M. J. Mol. Biol. (1995)
- Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. Shibata, S., Yamamoto-Goshima, F., Maeno, K., Hanaichi, T., Fujita, Y., Nakajima, K., Imai, M., Komatsu, T., Sugiura, S. J. Virol. (1993)
- Rescue of influenza B virus from eight plasmids. Hoffmann, E., Mahmood, K., Yang, C.F., Webster, R.G., Greenberg, H.B., Kemble, G. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Protection against influenza B virus infection by immunization with DNA vaccines. Chen, Z., Kadowaki, S., Hagiwara, Y., Yoshikawa, T., Sata, T., Kurata, T., Tamura, S. Vaccine (2001)
- Influenza B virus BM2 protein is transported through the trans-Golgi network as an integral membrane protein. Watanabe, S., Imai, M., Ohara, Y., Odagiri, T. J. Virol. (2003)
- Comparison of structure and sequence of influenza B/Yamagata and B/Beijing neuraminidases shows a conserved "head" but much greater variability in the "stalk" and NB protein. Burmeister, W.P., Baudin, F., Cusack, S., Ruigrok, R.W. Virology (1993)
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Gubareva, L.V. Virus Res. (2004)